Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shanghai Allist Pharmaceuticals Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥723 Mil. Shanghai Allist Pharmaceuticals Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0 Mil.
Shanghai Allist Pharmaceuticals Co's interest coverage for the quarter that ended in Mar. 2026 was 21,274.79.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Shanghai Allist Pharmaceuticals Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Shanghai Allist Pharmaceuticals Co's Interest Coverage or its related term are showing as below:
SHSE:688578'
s Interest Coverage Range Over the Past 10 Years
Min: 142.37 Med: 11313.69 Max: 23291.09
Current: 21523.37
SHSE:688578's Interest Coverage is ranked better than 99.73% of 377
companies
in the Biotechnology industry
Industry Median: 106.07
vs SHSE:688578: 21523.37
Shanghai Allist Pharmaceuticals Co (SHSE:688578) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shanghai Allist Pharmaceuticals Co Interest Coverage Related Terms
Shanghai Allist Pharmaceuticals Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shanghai Allist Pharmaceuticals Co Interest Coverage Chart
SHSE:688578 vs VRTX, REGN, RVMD: Interest Coverage Comparison
For the Biotechnology subindustry, Shanghai Allist Pharmaceuticals Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Allist Pharmaceuticals Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Allist Pharmaceuticals Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shanghai Allist Pharmaceuticals Co's Interest Coverage falls into.
Shanghai Allist Pharmaceuticals Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Allist Pharmaceuticals Co (SHSE:688578) has a Interest Coverage of 21,274.79 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shanghai Allist Pharmaceuticals Co and its competitors. This is 88% above median its historical median of 11,313.69. Over the past decade, Shanghai Allist Pharmaceuticals Co's Interest Coverage has ranged from 142.37 to 23,291.09. According to the industry distribution chart, Shanghai Allist Pharmaceuticals Co ranks #1 out of 377 companies in the Biotechnology industry, placing it in the top 0.3%.
Is Shanghai Allist Pharmaceuticals Co's Interest Coverage too high?
Shanghai Allist Pharmaceuticals Co's current Interest Coverage of 21,274.79 is 88% above median its 10-year median of 11,313.69. Over the past 10 years, this metric has ranged from a low of 142.37 to a high of 23,291.09. The Biotechnology industry median Interest Coverage is 106.07. Shanghai Allist Pharmaceuticals Co's value of 21,274.79 is 19957.3% above this industry median. Based on the distribution chart, Shanghai Allist Pharmaceuticals Co ranks #1 out of 377 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Allist Pharmaceuticals Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Allist Pharmaceuticals Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Allist Pharmaceuticals Co ranks #1 out of 377 companies for Interest Coverage. This places Shanghai Allist Pharmaceuticals Co in the top 0% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 106.07. Shanghai Allist Pharmaceuticals Co's value of 21,274.79 is 19957.3% above this benchmark. Historically, Shanghai Allist Pharmaceuticals Co's own Interest Coverage has ranged from 142.37 to 23,291.09 over the past decade. While the company's 10-year median is 11,313.69 vs. the industry median of 106.07, Shanghai Allist Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Allist Pharmaceuticals Co's current Interest Coverage of 21,274.79 is 19957.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shanghai Allist Pharmaceuticals Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Allist Pharmaceuticals Co's current Interest Coverage is 21,274.79, which is 88% above median its own 10-year median of 11,313.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Allist Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Allist Pharmaceuticals Co (SHSE:688578) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥135.47, compared to a current price of ¥111.20 — trading 17.9% below its estimated fair value. The current Interest Coverage is 21,274.79, which is 88% above median its 10-year median of 11,313.69 and 19957.3% above the Biotechnology industry median of 106.07. Shanghai Allist Pharmaceuticals Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shanghai Allist Pharmaceuticals Co (SHSE:688578), the current Interest Coverage is 21,274.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Allist Pharmaceuticals Co (SHSE:688578) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Allist Pharmaceuticals Co stock appears to be undervalued.
The current stock price of ¥111.20 is trading 17.9% below its estimated GF Value™ of ¥135.47.
GuruFocus considers Shanghai Allist Pharmaceuticals Co to be Modestly Undervalued.
Key valuation signals for SHSE:688578:
Interest Coverage: 21,274.79 (88% above median its 10-year median of 11,313.69)
GF Value™: ¥135.47 vs. price of ¥111.20 (17.9% below fair value)
Industry Position: 19957.3% above the Biotechnology median (#1 of 377)
No single metric tells the full story. See the SHSE:688578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688578 has been successfully added to your 
